<DOC>
	<DOCNO>NCT02816099</DOCNO>
	<brief_summary>In type-1 diabetes patient , bad cholesterol tend accumulate apoC1 function slow . ApoC1 protein whose role diminish activity CETP , another protein regulate cholesterol transfer body . The aim study determine whether possible correct apoC1 function improve glycaemic balance . 240 person recruit study allocate one two group : - 160 Type-1 diabetes patient uncontrolled diabetes : - 4 additional blood sample take time systematic biological examination inclusion 3 month later . - 80 control subject normal lipid normal glycaemia balance include study follow result biological assay . - 4 blood sample take time inclusion .</brief_summary>
	<brief_title>Influence Glycaemic Balance Ability Apolipoprotein C1 Inhibit Cholesteryl Ester Transfer Protein Type-1 Diabetes Patients</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion patient : Patients 18 year Patients type1 diabetes glycated hemoglobin ( HbA1C ) &gt; 9 % Inclusion criterion control : Subjects 18 year Normal glycaemia ( Fasting glycaemia &lt; 1.10 g/L ) normal lipid ( Lowdensity lipoproteins ( LDL ) &lt; 1.6 g/L , triglyceride ( TG ) &lt; 1.5 g/L ) Exclusion criterion patient : Adults guardianship Patients without national health insurance Pregnant breastfeed woman Progressive cancer Treatment able influence lipoprotein metabolism ( oestroprogestatives , immunosuppressant , longterm corticotherapy ) Exclusion criterion control : Adults guardianship Persons without national health insurance Pregnant breastfeed woman know dyslipidemia and/or lipidlowering treatment Treatment able influence lipoprotein metabolism ( oestroprogestatives , immunosuppressant , longterm corticotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>